Johnson RW - Search Results

1

Pharmacokinetics of cyclosporin: influence of rate of constant intravenous infusion in renal transplant patients.

Gupta SK, Legg B, Solomon LR, Johnson RW, Rowland M. Gupta SK, et al. Among authors: johnson rw. Br J Clin Pharmacol. 1987 Oct;24(4):519-26. doi: 10.1111/j.1365-2125.1987.tb03206.x. Br J Clin Pharmacol. 1987. PMID: 3318898 Free PMC article.

2

Pharmacokinetics of cyclosporin: influence of rate-duration profile of an intravenous infusion in renal transplant patients.

Gupta SK, Bakran A, Johnson RW, Rowland M. Gupta SK, et al. Among authors: johnson rw. Br J Clin Pharmacol. 1989 Mar;27(3):353-7. doi: 10.1111/j.1365-2125.1989.tb05376.x. Br J Clin Pharmacol. 1989. PMID: 2655684 Free PMC article.

3

Cyclosporin-erythromycin interaction in renal transplant patients.

Gupta SK, Bakran A, Johnson RW, Rowland M. Gupta SK, et al. Among authors: johnson rw. Br J Clin Pharmacol. 1989 Apr;27(4):475-81. doi: 10.1111/j.1365-2125.1989.tb05396.x. Br J Clin Pharmacol. 1989. PMID: 2655690 Free PMC article. Clinical Trial.

4

Cyclosporin: pharmacokinetics and detailed studies of plasma and erythrocyte binding during intravenous and oral administration.

Legg B, Gupta SK, Rowland M, Johnson RW, Solomon LR. Legg B, et al. Among authors: johnson rw. Eur J Clin Pharmacol. 1988;34(5):451-60. doi: 10.1007/BF01046701. Eur J Clin Pharmacol. 1988. PMID: 3203704

5

Erythromycin enhances the absorption of cyclosporin.

Gupta SK, Bakran A, Johnson RW, Rowland M. Gupta SK, et al. Among authors: johnson rw. Br J Clin Pharmacol. 1988 Mar;25(3):401-2. doi: 10.1111/j.1365-2125.1988.tb03320.x. Br J Clin Pharmacol. 1988. PMID: 3282533 Free PMC article. No abstract available.

6

Reduction of post-transplant proteinuria due to recurrent mesangial proliferative (IgM) glomerulonephritis following plasma exchange.

Solomon LR, Cairns SA, Lawler W, Johnson RW, Mallick NP. Solomon LR, et al. Among authors: johnson rw. Clin Nephrol. 1981 Jul;16(1):44-50. Clin Nephrol. 1981. PMID: 7023769

7

Late cellular rejection in renal transplant recipients.

Solomon LR, Martin S, Short CD, Lawler W, Gokal R, Johnson RW, Mallick NP. Solomon LR, et al. Among authors: johnson rw. Transplantation. 1986 Feb;41(2):262-4. doi: 10.1097/00007890-198602000-00025. Transplantation. 1986. PMID: 3511586 No abstract available.

8

Respiratory syncytial virus infection following renal transplantation.

Solomon LR, Raftery AT, Mallick NP, Johnson RW, Longson M. Solomon LR, et al. Among authors: johnson rw. J Infect. 1981 Sep;3(3):280-2. doi: 10.1016/s0163-4453(81)91003-3. J Infect. 1981. PMID: 6764495 No abstract available.

9

Donor seropositivity and prednisolone therapy as risk factors for cytomegalovirus infection and disease in cyclosporin-treated renal allograft recipients.

Morris DJ, Longson M, Poslethwaite RJ, Mallick NP, Johnson RW. Morris DJ, et al. Among authors: johnson rw. Q J Med. 1990 Nov;77(283):1165-73. doi: 10.1093/qjmed/77.2.1165. Q J Med. 1990. PMID: 2177208

10

Tacrolimus is not associated with gingival overgrowth in renal transplant patients.

James JA, Jamal S, Hull PS, Macfarlane TV, Campbell BA, Johnson RW, Short CD. James JA, et al. Among authors: johnson rw. J Clin Periodontol. 2001 Sep;28(9):848-52. doi: 10.1034/j.1600-051x.2001.028009848.x. J Clin Periodontol. 2001. PMID: 11493354

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

604 results

Search Page